Globus Return on Average Assets vs Total Liabilities Analysis

GMED Stock  USD 53.64  0.58  1.09%   
Trend analysis of Globus Medical balance sheet accounts such as Short and Long Term Debt Total of 546.4 M or Other Current Liab of 320.6 M provides information on Globus Medical's total assets, liabilities, and equity, which is the actual value of Globus Medical to its prevalent stockholders. By breaking down trends over time using Globus Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

About Globus Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Globus Medical at a specified time, usually calculated after every quarter, six months, or one year. Globus Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Globus Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Globus currently owns. An asset can also be divided into two categories, current and non-current.

Globus Medical Balance Sheet Chart

Globus Medical Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Globus Medical uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Globus Medical's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 320.6 M, whereas Current Deferred Revenue is forecasted to decline to about 9.6 M.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Globus Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Globus Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Globus Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Globus Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.The current year's Selling General Administrative is expected to grow to about 675.6 M, whereas Tax Provision is forecasted to decline to about 34.9 M.
 2021 2022 2023 2024 (projected)
Gross Profit718.9M759.1M1.0B533.4M
Total Revenue958.1M1.0B1.6B1.6B

Globus Medical fundamental ratios Correlations

0.70.490.530.690.730.70.680.720.270.830.760.540.690.540.550.90.680.990.530.650.750.580.590.660.74
0.70.930.90.991.00.841.00.790.670.580.960.931.00.810.590.671.00.710.950.990.990.980.970.981.0
0.490.930.960.950.910.670.940.610.820.260.880.920.940.680.40.40.950.521.00.960.890.990.990.90.92
0.530.90.960.930.880.670.910.60.880.270.910.810.90.630.350.430.920.570.960.930.870.950.960.880.9
0.690.990.950.930.990.830.990.770.730.530.960.910.990.760.550.630.990.710.970.990.980.990.980.970.99
0.731.00.910.880.990.860.990.810.630.630.960.921.00.830.620.70.990.730.930.990.990.960.960.981.0
0.70.840.670.670.830.860.820.90.420.710.790.710.830.670.660.780.810.70.730.820.830.770.770.90.86
0.681.00.940.910.990.990.820.770.680.560.950.931.00.820.590.651.00.690.960.990.990.980.980.970.99
0.720.790.610.60.770.810.90.770.310.780.750.690.780.720.630.830.770.710.660.770.790.710.70.850.8
0.270.670.820.880.730.630.420.680.31-0.030.680.530.670.290.020.140.70.320.80.710.610.760.780.640.66
0.830.580.260.270.530.630.710.560.78-0.030.610.410.570.640.660.930.550.790.310.50.650.410.390.590.6
0.760.960.880.910.960.960.790.950.750.680.610.830.950.770.510.680.970.770.890.950.960.930.920.940.97
0.540.930.920.810.910.920.710.930.690.530.410.830.930.810.580.50.920.550.930.940.90.940.930.890.91
0.691.00.940.90.991.00.831.00.780.670.570.950.930.810.580.651.00.690.960.990.990.980.980.980.99
0.540.810.680.630.760.830.670.820.720.290.640.770.810.810.70.670.810.540.70.780.850.750.730.810.8
0.550.590.40.350.550.620.660.590.630.020.660.510.580.580.70.720.550.540.440.560.640.490.480.550.61
0.90.670.40.430.630.70.780.650.830.140.930.680.50.650.670.720.630.880.450.60.710.520.520.670.7
0.681.00.950.920.990.990.811.00.770.70.550.970.921.00.810.550.630.690.960.990.980.980.980.970.99
0.990.710.520.570.710.730.70.690.710.320.790.770.550.690.540.540.880.690.560.660.750.610.610.670.74
0.530.951.00.960.970.930.730.960.660.80.310.890.930.960.70.440.450.960.560.980.910.991.00.920.94
0.650.990.960.930.990.990.820.990.770.710.50.950.940.990.780.560.60.990.660.980.970.990.990.970.99
0.750.990.890.870.980.990.830.990.790.610.650.960.90.990.850.640.710.980.750.910.970.950.940.960.99
0.580.980.990.950.990.960.770.980.710.760.410.930.940.980.750.490.520.980.610.990.990.951.00.950.97
0.590.970.990.960.980.960.770.980.70.780.390.920.930.980.730.480.520.980.611.00.990.941.00.950.96
0.660.980.90.880.970.980.90.970.850.640.590.940.890.980.810.550.670.970.670.920.970.960.950.950.98
0.741.00.920.90.991.00.860.990.80.660.60.970.910.990.80.610.70.990.740.940.990.990.970.960.98
Click cells to compare fundamentals

Globus Medical Account Relationship Matchups

Globus Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding102.0M101.0M103.6M102.6M114.6M104.1M
Total Assets1.5B1.7B2.0B2.1B5.1B5.3B
Other Current Liab6.7M5.8M11.8M106.5M305.3M320.6M
Total Current Liabilities111.4M120.8M140.2M159.2M392.3M412.0M
Total Stockholder Equity1.4B1.5B1.7B1.8B4.0B4.2B
Other Liab17.1M52.4M75.7M70.5M81.1M85.2M
Property Plant And Equipment Net199.8M216.9M221.1M243.7M646.9M679.2M
Current Deferred Revenue5.4M8.1M12.0M14.1M18.4M9.6M
Net Debt(193.2M)(234.6M)(188.0M)(144.5M)53.1M55.8M
Retained Earnings1.0B1.0B1.2B1.2B1.1B764.6M
Accounts Payable24.6M18.2M22.0M36.1M56.7M59.5M
Cash195.7M239.4M193.1M150.5M467.3M490.7M
Non Current Assets Total844.6M857.7M1.1B1.1B3.2B3.3B
Non Currrent Assets Other21.7M32.0M36.3M43.3M78.6M82.5M
Other Assets25.2M209.8M60.8M92.2M106.0M111.3M
Cash And Short Term Investments311.5M426.7M443.4M446.1M517.8M342.9M
Net Receivables162.4M148.1M165.7M217.3M504.9M530.1M
Liabilities And Stockholders Equity1.5B1.7B2.0B2.1B5.1B5.3B
Non Current Liabilities Total18.2M52.4M75.7M70.5M695.8M730.6M
Inventory196.3M229.2M237.0M299.0M848.1M890.5M
Other Current Assets17.2M17.8M18.4M21.0M44.6M46.8M
Other Stockholder Equity357.3M457.2M553.8M631.0M2.9B3.0B
Total Liab129.6M173.2M215.9M229.8M1.1B1.1B
Property Plant And Equipment Gross199.8M216.9M526.7M586.8M1.1B1.1B
Total Current Assets687.5M821.8M864.5M983.3M1.9B2.0B
Accumulated Other Comprehensive Income(2.9M)4.0M(6.8M)(24.6M)(10.2M)(9.7M)
Short Term Debt74.7M88.7M94.4M2.5M12.0M11.4M
Property Plant Equipment202.3M216.9M221.1M243.7M280.3M146.5M
Good Will128.8M156.7M179.7M197.5M1.4B1.5B
Intangible Assets78.8M86.9M68.7M63.6M924.6M970.8M
Net Tangible Assets1.2B1.3B1.5B1.6B1.8B981.4M
Short Term Investments115.8M187.3M250.4M295.6M50.5M48.0M
Capital Surpluse357.3M457.2M553.8M631.0M725.6M761.9M
Non Current Liabilities Other12.2M46.2M71.4M68.8M102.9M108.1M
Long Term Investments409.5M358.5M562.5M495.9M75.4M71.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
1.07
Revenue Per Share
13.87
Quarterly Revenue Growth
1.246
Return On Assets
0.0477
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.